C84.33 Lymphoepithelioid lymphoma, intra-abdominal lymph nodes

Name of the Condition

• Lymphoepithelioid lymphoma, intra-abdominal lymph nodes (ICD-10 Code: C84.33)

Summary

Lymphoepithelioid lymphoma, intra-abdominal lymph nodes, is a rare subtype of mature T-cell lymphoma characterized by a distinctive histological pattern of epithelioid histiocytes and small lymphocytes. It typically presents as localized lymphadenopathy in intra-abdominal lymph nodes and may involve extranodal sites. The condition is part of the broader category of peripheral T-cell lymphomas and is distinguished by its unique cellular composition, though its clinical behavior can vary.

Causes

The exact cause of lymphoepithelioid lymphoma is not fully understood. It is believed to involve genetic alterations in T-lymphocytes, leading to abnormal proliferation and tissue infiltration. Chronic antigen stimulation or immune dysregulation may contribute to its development, though specific triggers remain unclear. No consistent association with viral infections has been established.

Risk Factors

• Age: More common in adults, particularly those over 50.
• Immunosuppression: Conditions or treatments that weaken the immune system may increase risk.
• Genetic predisposition: Family history of lymphoma or related disorders.
• Ethnicity: Some studies suggest higher prevalence in certain populations, though data is limited.

Symptoms

• Painless swelling of lymph nodes (lymphadenopathy) in the abdominal region.
• Abdominal pain or discomfort.
• Unexplained weight loss.
• Fever or night sweats.
• Fatigue or weakness.

Diagnosis

Diagnosis typically involves a combination of clinical evaluation, imaging studies (e.g., CT or MRI) to assess lymph node involvement, and histopathological examination of tissue samples obtained via biopsy. Immunohistochemical staining and molecular testing may be used to confirm the presence of T-cell markers and rule out other lymphoma subtypes. Staging may include additional tests to determine the extent of disease.

Treatment Options

Treatment depends on the stage and aggressiveness of the lymphoma. Options may include chemotherapy, targeted therapy, or immunotherapy. Radiation therapy may be considered for localized disease. Clinical trials or specialized protocols may be recommended for rare subtypes. Treatment plans are individualized based on patient factors and disease characteristics.

Prognosis and Follow-Up

Prognosis varies and depends on factors such as disease stage, response to treatment, and overall health. Regular follow-up with imaging and clinical assessments is typically recommended to monitor for recurrence or progression. Long-term surveillance may be necessary, as some cases can have an indolent course or relapse.

Complications

• Disease progression or transformation to a more aggressive lymphoma.
• Organ dysfunction due to lymph node enlargement or infiltration.
• Treatment-related side effects (e.g., from chemotherapy or radiation).
• Increased risk of infections due to immunosuppression.

Lifestyle & Prevention

• Maintain a healthy lifestyle to support immune function.
• Avoid known immunosuppressive factors (e.g., smoking, excessive alcohol).
• Follow recommended cancer screening guidelines.
• Discuss family history with a healthcare provider to assess genetic risk.

When to Seek Professional Help

Seek medical attention if you experience persistent abdominal swelling, unexplained weight loss, fever, or other concerning symptoms. Early evaluation is important for timely diagnosis and management.

Tips for Medical Coders

• Use C84.33 for lymphoepithelioid lymphoma specifically involving intra-abdominal lymph nodes.
• Ensure documentation supports the anatomical site (intra-abdominal) to justify code assignment.
• Verify that the condition is not better classified under a more specific lymphoma code or another category.
• Confirm the histological subtype (lymphoepithelioid) is documented to align with the code’s definition.